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achieving the ultimate goal of engineering a functional heart, how-
ever, some challenges regarding the scaffold preparation and the
sources of seeding cells still need to be addressed. The purpose of this
study was to establish and optimized the methodology of decellular-
ized heart scaffold. It’s also expected to establish a platform for the
decellularied heart tissue-based scaffold evaluation in vitro.
METHODS The decellularized heart scaffold was prepared by coronary
perfusion. Histological staining, DNA content assay and scanning electron
microscopy (SEM) were performed to evaluate the decellularized heart
scaffold. Neonatal rat cardiac cells and rat bone marrow multipotent stro-
mal cells (rBMSCs), which have the potential to transdifferentiate into
cardiomyocytes, were adopted to serve as seed cells respectively to
construct a tissue-engineered 3D cardiac model. To improve the viability
of cells on 3D scaffold, rotary cell culture system (RCCS) was also applied
to enhance the mass transport during the cultivation in vitro. The tissue-
engineered 3D model was evaluated by histological staining, SEM as well
as quantitative real-time RT-PCR analysis.
RESULTS Both histological staining and SEM detection revealed that
decelluarized heart scaffold preserves the ultrastructural conforma-
tion of the heart with few nuclei. The DNA content of the scaffold was
1.640.03ng/mg, which is signiﬁcantly lower than that of the control
group (native heart tissue). Histological staining and SEM images
showed their good viability during the 3D culture. Majority of the
seeded neonatal rat cardiac cells or rBMSCs grow on the surface of the
scaffold under the static culture condition. By contrast, a number of
cells distributing within the scaffolds were observed in the dynamic
cultures, indicating its good mass transport and microenvironment for
cell growth. Quantitative real-time RT-PCR analysis revealed that
expression level of transcript factor Gata 4 in the induced rBMSCs was
improved signiﬁcantly when compared to the negative control.
Similarly, the expression of gene Gata4 in the rBMSCs inoculated into
the decelluarized heart scaffold is much higher than that of the
negative control and the induced group (5-azacytidine-treated).
CONCLUSIONS The decellularized heart scaffolds prepared in the
present study were decellularized completely and preserved the full
extracellular matrix. It possesses not only good biocompatibility but
also naturally occurring three-dimensional structure. Moreover, our
research indicates that the decellularized heart scaffold might
potentially induce the differentiation of rBMSCs into cardiomyocytes.
Combined with the RCCS cultivation, the tissue-engineered 3D cardiac
model based on decellularized heart scaffold can better simulate the
microenvironment in vivo and might potentially be utilized for car-
diac tissue engineering.
GW26-e2370
Red Cell Distribution Width and Risk of Long-Term All-Cause Mortality and
Cardiovascular Events Among Patients With Acute Coronary Syndrome: A
Meta-Analysis of Observational Studies
Yun Zhou, Dongze Li, Yining Yang, Yitong Ma
Department of Cardiology, First Afﬁliated Hospital of Xinjiang Medical
University
OBJECTIVES Red cell distribution width (RDW) might be a novel
biomarker that reﬂects multiple physiological impairments related to
atherosclerosis and acute coronary syndrome (ACS). We conducted
this systematic review and meta-analysis to evaluate the association
of RDW between risk of major adverse cardiovascular Events (MACEs),
all-cause and cardiovascular mortality in ACS patients.
METHODS Relevant studies were searched and identiﬁed in the
Cochrane Library, PubMed and Embase databases. English-language
studies that reported risk estimates for RDW and MACEs, all-cause
and cardiovascular mortality were included. Data were extracted
regarding the characteristics and clinical outcomes, and a quality
assessment was conducted. Results were extracted for the average
RDW level, and meta-analyses were carried out using random effects
models.
RESULTS We collected 14 articles. 9 investigated the association
between RDW and all-cause mortality, 3 evaluated the association
between RDW and risk of cardiovascular mortality, and 7 reported the
association between RDW and risk of MACEs. We found that RDW was
associated with a signiﬁcantly increased risk of all-cause mortality
(HR:3.372; 95%CI:2.014 - 5.645; P <0.001), cardiovascular mortality
(HR: 2.342; 95%CI: 1.769 - 3.100; P <0.001) and MACEs (HR: 2.120; 95%
CI: 1.515-2.965; P <0.001;).
CONCLUSIONS The meta-analysis indicates that RDW signiﬁcantly
increased the risk of MACEs, all-cause and cardiovascular mortality
in ACS patients.GW26-e5367
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OBJECTIVES Recent evidence implicates SIRT3 as a central regulator
of mitochondrial redox balance and metabolic homeostasis but the
contribution of SIRT3 to vascular function remains unknown. The aim
of this study was to investigate the role of SIRT3 in obesity-induced
endothelial insulin resistance and subsequent vascular dysfunction.
METHODS Both vascular response to insulin and SIRT3 expression
were detected in morbid obese human subjects undergoing bariatric
surgery and non-obese controls. Male SIRT3 knockout mice and wide
type littermates were fed with a standard chow diet or a high fat diet
(HFD) for 24 weeks.
RESULTS We found an impaired insulin-induced mesenteric vaso-
relaxation (82.468.5% vs. 54.936.46%, n¼8-12, P<0.05) and
concomitant a 50% reduced vascular SIRT3 expression in morbid obese
human subjects compared with non-obese controls. Downregulation of
SIRT3 either by siRNA or by palmitate excess treatment in cultured
human endothelial cells resulted in overproduction of mitochondrial
reactive oxygen species (mtROS) and impaired insulin signaling as
indicated by decreased phosphorylation of Akt and eNOS and subse-
quent reduced NO release. Additionally, obese mice induced by 24-week
HFD displayed an impaired endothelium-dependent vasorelaxation to
both insulin (40.68  3.68% vs. 64.98  2.85%, n ¼ 8, P < 0.01) and
acetylcholine (46.45  4.93% vs. 100.59  2.35%, n ¼ 6, P < 0.01), which
was further exacerbated by gene deletion of SIRT3 (P < 0.05). Moreover,
lentivirus-mediated restoration of vascular SIRT3 rescued HFD-induced
endothelial dysfunction in SIRT3 knockout mice (46.84  3.29% vs.
29.56  2.99%, n ¼ 6, P < 0.01 for response to insulin; 75.59  4.93% vs.
57.25  3.81%, n ¼ 6, P < 0.01 for response to acetylcholine). Elimination
of mtROS with MitoTEMPO not only restored insulin-stimulated
NO production in SIRT3 knockdown cells but also improved insulin-
induced vasorelaxation in SIRT3 knockout mice fed with HFD.
CONCLUSIONS Our ﬁndings suggest that SIRT3 positively regulates
endothelial insulin sensitivity and show that SIRT3 deﬁciency and
resultant mtROS overproduction contribute to vascular dysfunction in
obesity.
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OBJECTIVES Diabetes mellitus (DM) is one of the greatest public
health threats in modern societies. And among all the diabetic com-
plications, diabetic cardiomyopathy (DCM) has been recognized as the
leading cause of morbidity and mortality. Thus, the elucidation of
pathological mechanisms in DCM is urgently needed, so as to develop
novel therapies. Fenoﬁbrate (FF) is a peroxisome proliferator-acti-
vated receptor-a (PPARa) agonist. It has long been used clinically to
lower lipid levels for about three decades. Here we tested whether FF
can be repurposed to prevent diabetic cardiomyopathy (DCM) for type
1 diabetes, and delineated the mechanism of its action.
METHODS Streptozotocin (STZ) was used to induce type 1 diabetes in
wild type C57BL/6J mice and ﬁbroblast growth factor 21 knock-out
(FGF21KO) mice, diabetic and age-matched control mice were then
treated with vehicle or FF by gavage every other day for 3 or 6 months.
After that we sacriﬁced the animal models and obtained heart tissue
for further study including western blot assay, real-time PCR, pa-
thology staining and so on. The H9c2 cardiac myoblast cells were used
for the in vitro study.
RESULTS FF prevented diabetes-induced cardiac dysfunction as well
as cardiac inﬂammation, oxidative stress and remodeling (PAI-1,
TNFa, 3NT, 4HNE, CTGF, TGFb), along with up-regulated cardiac
expression of FGF21 and sirtuin1 (Sirt1). In contrast to wild-type dia-
betic mice, FGF21-KO mice showed worse biochemical, pathological,
and functional changes of the heart following diabetes induction, and
failed to respond to FF treatment even though FF similarly lowered
systemic lipid proﬁle in both WT and FGF21-KO diabetic mice.
